Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 66Terminated 11Unknown 4Withdrawn 2Recruiting 2Active not recruiting 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2CNS 2

Conditions

Prostatic Neoplasms 31Squamous Cell Carcinoma of Head and Neck 22Carcinoma, Non-Small-Cell Lung 20Breast Neoplasms 18Neoplasms 17Glioblastoma 17Esophageal Squamous Cell Carcinoma 16Rectal Neoplasms 15Esophageal Neoplasms 15Lung Neoplasms 14Head and Neck Neoplasms 13Uterine Cervical Neoplasms 11Neoplasm Metastasis 10Glioma 10Oropharyngeal Neoplasms 8Nasopharyngeal Carcinoma 8Stomach Neoplasms 7Radiation Injuries 7Brain Neoplasms 7Hyperthermia 6Carcinoma, Hepatocellular 6Astrocytoma 6Urinary Bladder Neoplasms 5Small Cell Lung Carcinoma 5Sarcoma 5Oligodendroglioma 5Colorectal Neoplasms 5Carcinoma, Renal Cell 5Triple Negative Breast Neoplasms 4Pancreatic Neoplasms 4

Interventions

pembrolizumab 3Temozolomide 3Specimen Handling 3Radiotherapy 2peposertib 1liposomal doxorubicin 1gosha-jinki-gan 1efineptakin alfa 1cabozantinib 1balstilimab 1atezolizumab 1abexinostat 1Surgical Procedures, Operative 1Radiation 1ONC206 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Gliosarcoma × Radiotherapy × Clear all
NCT04555577 2026-05-20

Peposertib and Radiation Therapy, Followed by Temozolomide for the Treatment of Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma or Gliosarcoma

M.D. Anderson Cancer Center

Phase 1 Recruiting
29 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

NCT06934889 2026-05-14

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

Memorial Sloan Kettering Cancer Center

Phase 1 Recruiting
60 enrolled
CNSSarcoma

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡